Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor
Navigation Menu

Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor

New targeted therapies have potential to improve overall survival for patients with EGFR-mutation positive NSCLC

Posted by on Aug 8, 2018 in Lung cancer | 0 comments

In a nutshell This study compared dacomitinib (PF-00299804) to gefitinib (Iressa) as a first treatment for patients with EGFR-mutation positive non-small-cell lung cancer. The authors concluded that treatment with dacomitinib provided an improved overall survival compared to gefitinib. Some background Current cancer therapy heavily...

Read More

Comparing targeted therapy to chemotherapy for patients with advanced NSCLC

Posted by on Aug 8, 2018 in Lung cancer | 0 comments

In a nutshell This trial compared the effectiveness of alectinib (Alecensa) against chemotherapy for treating patients with ALK-positive non-small-cell lung cancer that have progressed passed previous targeted therapy. The authors determined that alectinib was more effective than chemotherapy at treating this subgroup of patients. Some background Lung...

Read More

Is targeted therapy better at treating advanced NSCLC than current chemotherapy treatment?

Posted by on Apr 21, 2018 in Lung cancer | 0 comments

In a nutshell This study examined the effectiveness of the targeted therapy drug nivolumab (Opdivo) at treating advanced non-small-cell lung cancer, particularly for patients with cancer that has spread to the liver. The authors concluded that nivolumab led to an improved overall survival compared to chemotherapy for these patients. Some background...

Read More

The socioeconomic impact of cachexia in elderly patients with advanced lung cancer

Posted by on Apr 9, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at the impact of cachexia (weakness or wasting of the body) in elderly patients with advanced non-small-cell lung cancer on disability, hospitalization and medical costs. The authors concluded that patients with cachexia had a higher risk of disability, longer hospital stays and higher medical costs, while being treated...

Read More

Combining the old and the new – Can combination therapy improve cancer treatment?

Posted by on Jan 29, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at combining therapies designed to stimulate the immune system with chemotherapy to treat patients with advanced lung cancer. The authors concluded that a combination of immune checkpoint inhibitors and chemotherapy is effective and tolerable at treating these patients. Some background Many tumor cells have proteins...

Read More

Is there a benefit in combining radiation treatments for patients with limited brain metastases?

Posted by on Jan 17, 2018 in Lung cancer | 0 comments

In a nutshell This study examined the effectiveness of whole brain radiation therapy (WBRT) at treating non-small-cell lung cancer (NSCLC) that has spread to the brain. The trial focused on patients with few brain metastases (tumors that spread) and combined WBRT with stereotactic radiosurgery (SRS). The authors concluded that they did not find a...

Read More

Can acupuncture improve fatigue during cancer treatment?

Posted by on Jan 8, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at whether acupuncture could improve cancer related fatigue for patients with non-small-cell lung cancer (NSCLC). The authors concluded that acupuncture is safe and may be beneficial at improving fatigue in these patients during their treatment regimes. Some background Fatigue is one of the most common side effects...

Read More

Comparing targeted therapies for patients with advanced non-small-cell lung cancer

Posted by on Dec 16, 2017 in Lung cancer | 0 comments

In a nutshell The authors aimed to understand the effectiveness of anti-PD-L1 therapy in patients with previously treated non-small-cell lung cancer (NSCLC) compared to current treatments. The authors concluded that anti-PD-L1 therapy could be more beneficial than the chemotherapy drug docetaxel (Taxotere) at treating patients with previously treated...

Read More